Griffon G, Merlin J L, Marchal C
Laboratoire de Recherche en Oncologie, Centre Alexis Vautrin, Vandoeuvre-les-Nancy, France.
Anticancer Drugs. 1995 Feb;6(1):115-23. doi: 10.1097/00001813-199502000-00014.
The radiation sensitivity of six human ovarian tumor cell lines was evaluated using sulforhodamine B (SRB), tetrazolium (MTT) and clonogenic assays. Radiobiological parameters calculated from a linear quadratic model (SF2, alpha, beta) as well as from a single-hit multitarget model (D(o), Dq, n) and from the area under the dose-response curve (mean inactivation dose; MID) were compared. If the values deduced from MTT experiments were statistically comparable to those obtained from clonogenic assays, significant differences were observed between SRB and the two other assays that concerned the results achieved with the highest radiation doses tested (6-8 Gy), yielding a surviving fraction of approximately 20%. In addition, the intra- and inter-experimental variation of SRB dramatically increased within this range of radiation doses. However, up to 6 Gy, the SRB assay proved to be statistically comparable to MTT and clonogenic assays, and allowed the calculation of SF2, alpha and MID radiobiological parameters.
使用磺酰罗丹明B(SRB)、四氮唑(MTT)和克隆形成试验评估了六种人卵巢肿瘤细胞系的辐射敏感性。比较了根据线性二次模型(SF2、α、β)以及单靶多靶模型(D(o)、Dq、n)和剂量反应曲线下面积(平均失活剂量;MID)计算的放射生物学参数。如果MTT实验得出的值与克隆形成试验获得的值具有统计学可比性,则在SRB与其他两种涉及最高测试辐射剂量(6-8 Gy)所取得结果的试验之间观察到显著差异,产生的存活分数约为20%。此外,在该辐射剂量范围内,SRB的实验内和实验间变异显著增加。然而,在高达6 Gy时,SRB试验被证明与MTT和克隆形成试验具有统计学可比性,并允许计算SF2、α和MID放射生物学参数。